RespiResponse Dosing Weekly  Therapeutic Peptide Dose 1 Treatment as needed


RespiResponse WBC Antibody TCR Peptides Trivalent Therapeutic Vaccine TreatmentT cell receptor (TCR) peptides (BV2.1, BV4.1, BV13S1) vaccine  Dose 1: Weekly as

needed 90% Gene Coverage 95% Confidence Interval in Lyophlized Amino Acid Acetate powder reconstituted in two Adjuvants .09% Sodium Chloride & IFA mineral oil creates emulsion >>>> RespiResponse Dose 1 Therapeutic Vaccine 


RespiResponse Immunity Dosing Dose 2:  Two Injections 90 Days Apart Booster


RespiResponse Immunity Dose 2: is derived from Coronavirus 2 (SARS-Cov-2) composed of  depleted S Protien Envelope propagated in HUT-78 cells and inactivated in beta-propiolactone and Gamma irradiation. The inactivated material is emulsified with mineral oil (Incomplete Freund's Adjuvant) at 1:1 ratio. Each 1 ml dose (at least 100µg or 10 units) has viral protein Depleted

S Protien Envelope. Two Adjuvants .09% Sodium Chloride & IFA mineral oil creates emulsion  >>>>>>> RespiResponse Immunity Dose 2

 Immune Response BioPharma, Inc. 2010-2025 (c)   


RespiResponse Universal SARS-Cov-2 Vaccine

Immune Response Biopharma, Inc. TM (c) 2010-2025